Intensity Therapeutics, Inc.INTSNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+41.7%
5Y CAGR+37.5%
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+41.7%/yr
Annual compound
5Y CAGR
+37.5%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
4.9x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
2024$6.09M+79.8%
2023$3.39M+40.0%
2022$2.42M+13.0%
2021$2.14M+82.5%
2020$1.17M-5.3%
2019$1.24M-